Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Reactivating drug research programmes

Gene profiling technology offers new avenues for producing precision drugs

- PMLiVE

Merck suspends two Keytruda trials after patient deaths

Investigators to look at Keytruda with Pomalyst and Revlimid

- PMLiVE

Trial of J&J’s canagliflozin boosts SGLT2 cardiovascular credentials

Invokana cuts risk of heart failure hospitalisation by a third

- PMLiVE

Regret Minimisation

When new products approach the market the level of demand for them is often exaggerated.

- PMLiVE

Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

He also takes up the CSO role at the UK biotech

- PMLiVE

The Communiqué Awards at 20: Catherine Warne

The Redhead Associates partner, and former Health Unlimited CEO, on the 'best networking event of the year'

- PMLiVE

Lucid strikes £11m investment deal with equity firm LDC

Will use the new funds to underpin its infrastructure as it grows

- PMLiVE

Angie Wiles launches The Difference Collective

Says virtual health communications venture is first of its kind

- PMLiVE

Pfizer hits accelerator on Xtandi trial in early prostate cancer

US pharma giant expects PROSPER trial results later this year

- PMLiVE

Spotlight on Events

Porterhouse has delivered many successful global programmes in 2017 so far. Read about our dedicated events team ...

Porterhouse Medical Group

- PMLiVE

Novo says real-world data backs its insulin switching

EU-TREAT study shows Tresiba improved blood glucose control

- PMLiVE

Endo faces industry-first FDA call to pull its opioid painkiller

Misuse of Opana ER has been associated with a ‘serious’ HIV and hep C outbreaks

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links